Penoliad, Evie A.
HRN: 20-75-65 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/11/2022
CEFTAZIDIME 1GM (VIAL)
12/11/2022
12/18/2022
IV
2g
Q8
Diabetic Foot
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes